Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Asc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
Mitsopoulos, E., Ginikopoulou E., Economidou D., Zanos S., Pateinakis P., Minasidis E., et al. (2012).  Impact of long-term cinacalcet, ibandronate or teriparatide therapy on bone mineral density of hemodialysis patients: a pilot study.. Am J Nephrol. 36(3), 238-44.
Mitsiou, E. K., Athyros V. G., Karagiannis A., & Mikhailidis D. I. (2012).  Is there a role for hypolipidaemic drug therapy in the prevention or treatment of microvascular complications of diabetes?. Open Cardiovasc Med J. 6, 28-32.
Mitsiou, M., Dimitros E., Roumeliotis S., Liakopoulos V., Kouidi E., & Deligiannis A. (2022).  Effects of a Combined Intradialytic Exercise Training Program and Music on Cardiac Autonomic Nervous System Activity in Hemodialysis Patients.. Life (Basel). 12(8), 
Mitsiou, E. K., Tziomalos K., Anagnostis P., Karagiannis A., & Athyros V. G. (2009).  Multifactorial intervention for the prevention of vascular complications of type 2 diabetes.. Hellenic J Cardiol. 50(6), 445-8.
Mitsiou, E., Boutari C., Kotsis V., Georgianou E., Doumas M., Karagiannis A., et al. (2018).  Effect of Low (5 mg) vs. High (20-40 mg) Rosuvastatin Dose on 24h Arterial Stiffness, Central Haemodynamics, and Non-Alcoholic Fatty Liver Disease in Patients with Optimally Controlled Arterial Hypertension.. Curr Vasc Pharmacol. 16(4), 393-400.
Mitsiakos, G., Gialamprinou D., Chouchou P., Chatziioannidis I., & Karagianni P. (2019).  Identification of a homozygous deletion of the NEU1 gene in a patient with type II sialidosis presenting isolated fetal ascites and central nervous system hypoplasia.. Hippokratia. 23(4), 169-171.
Mitsiakos, G., Kovacs L., & Papageorgiou A. (2013).  Are antenatal steroids beneficial to severely growth restricted fetuses?. J Matern Fetal Neonatal Med. 26(15), 1496-9.
Mitsiakos, G., Karametou M., Gkampeta A., Karali C., Papathanasiou A. Eirini, Papacharalambous E., et al. (2019).  Effectiveness and Safety of 4-factor Prothrombin Complex Concentrate (4PCC) in Neonates With Intractable Bleeding or Severe Coagulation Disturbances: A Retrospective Study of 37 Cases.. J Pediatr Hematol Oncol. 41(3), e135-e140.
Mitsiakos, G., Papaioannou G., Giougi E., Karagianni P., Garipidou V., & Nikolaidis N. (2007).  Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.. J Pediatr Hematol Oncol. 29(3), 145-50.
Mitsiakos, G., Papaioannou G., Papadakis E., Chatziioannidis E., Giougi E., Karagianni P., et al. (2009).  Haemostatic profile of full-term, healthy, small for gestational age neonates.. Thromb Res. 124(3), 288-91.
Mitsiakos, G., Pana Z-D., Chatziioannidis I., Piltsouli D., Lazaridou E., Koulourida V., et al. (2015).  Platelet Mass Predicts Intracranial Hemorrhage in Neonates With Gram-negative Sepsis.. J Pediatr Hematol Oncol. 37(7), 519-23.
Mitsiakos, G., Giougi E., Tsakalidis C., Kourti M., Chatziionnidis H., Karagianni P., et al. (2009).  A case of Adams-Oliver syndrome following in vitro fertilization.. Hum Reprod. 24(6), 1529-30.
Mitsiakos, G., Giougi E., Chatziioannidis I., Karagianni P., Papadakis E., Tsakalidis C., et al. (2010).  Haemostatic profile of healthy premature small for gestational age neonates.. Thromb Res. 126(2), 103-6.
Mitsiakos, G., & Papageorgiou A. (2016).  Incidence and factors predisposing to retinopathy of prematurity in inborn infants less than 32 weeks of gestation.. Hippokratia. 20(2), 121-126.
Mitsiakos, G., Giougi E., Papaioannou G., Karagianni P., Papadakis E., & Nikolaidis N. (2009).  Influence of smoking during pregnancy on haemostasis in healthy full term neonates.. Thromb Res. 123(3), 476-81.
Mitsiakos, G., Tsakalidis C., Karagianni P., Gialamprinou D., Chatziioannidis I., Papoulidis I., et al. (2019).  A New Gene Mutation c.3445G>A (p.Asp1149Asn) as a Causative Agent of Newborn Lethal Respiratory Distress Syndrome.. Medicina (Kaunas). 55(7), 
Mitsiades, C. S., Hayden P., Kotoula V., McMillin D. W., McMullan C., Negri J., et al. (2007).  Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition.. J Clin Endocrinol Metab. 92(12), 4845-52.
Mitsiades, N., Poulaki V., Kotoula V., Mastorakos G., Tseleni-Balafouta S., Koutras D. A., et al. (1998).  Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis.. J Clin Endocrinol Metab. 83(6), 2199-203.
Mitsiades, C. S., Kotoula V., Poulaki V., Sozopoulos E., Negri J., Charalambous E., et al. (2006).  Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis.. J Clin Endocrinol Metab. 91(9), 3662-6.
Mitsiades, N., Poulaki V., Kotoula V., Leone A., & Tsokos M. (1998).  Fas ligand is present in tumors of the Ewing's sarcoma family and is cleaved into a soluble form by a metalloproteinase.. Am J Pathol. 153(6), 1947-56.
Mitsiades, N., Chew S. Anne, He B., Riechardt A. I., Karadedou T., Kotoula V., et al. (2011).  Genotype-dependent sensitivity of uveal melanoma cell lines to inhibition of B-Raf, MEK, and Akt kinases: rationale for personalized therapy.. Invest Ophthalmol Vis Sci. 52(10), 7248-55.
Mitsiades, C. S., McMillin D., Kotoula V., Poulaki V., McMullan C., Negri J., et al. (2006).  Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro.. J Clin Endocrinol Metab. 91(10), 4013-21.
Mitsiades, N., Poulaki V., Mastorakos G., Tseleni-Balafouta S. T., Kotoula V., Koutras D. A., et al. (1999).  Fas ligand expression in thyroid carcinomas: a potential mechanism of immune evasion.. J Clin Endocrinol Metab. 84(8), 2924-32.
Mitrousias, V., Karachalios T. S., Varitimidis S. E., Natsis K., Arvanitis D. L., & Zibis A. H. (2020).  Anatomy Learning from Prosected Cadaveric Specimens Versus Plastic Models: A Comparative Study of Upper Limb Anatomy.. Anat Sci Educ. 13(4), 436-444.
Mitroulis, I., Kambas K., Anyfanti P., Doumas M., & Ritis K. (2011).  The multivalent activity of the tissue factor-thrombin pathway in thrombotic and non-thrombotic disorders as a target for therapeutic intervention.. Expert Opin Ther Targets. 15(1), 75-89.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.